Clicking a link below will scroll the
page down to the relevant section
- A Phase II Study of Pre-Operative Chemotherapy Plus Bevacizumab with Early Salvage Therapy in Patients with Locally Advanced Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
Shah, Manish, MD
[Protocol 08-081]
- A Phase II Trial of Cetuximab plus Cisplatin and Irinotecan in Patients with Irinotecan- and Cisplatin-Refractory Metastatic Esophageal and Gastric Cancer
Ilson, David, MD
[Protocol 06-095]
- A Phase II Trial of Irinotecan, Cisplatin, Bevacizumab, and Concurrent Radiotherapy in Locally Advanced Esophageal Adenocarcinoma
Ilson, David, MD
[Protocol 06-013]
- A Phase III Study Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Treated without Surgery
Goodman, Karyn, MD
[Protocol 09-066]
- Phase II Trial of Sorafenib for Patients with Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer
Ilson, David, MD
[Protocol 09-016]
- Quality of Life Outcomes Following Treatment for Esophageal Cancer
Bains, Manjit, MD
[Protocol 03-083]
- A Multicenter Phase II Study of Irinotecan and Alvocidib (Flavopiridol)
versus Irinotecan Alone for Patients with p53 Wild-Type Gastric Adenocarcinoma Whose Disease Has Progressed on One Line of Treatment
Shah, Manish, MD
[Protocol 09-074]
- A Phase II Study of Pre-Operative Chemotherapy Plus Bevacizumab with Early Salvage Therapy in Patients with Locally Advanced Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
Shah, Manish, MD
[Protocol 08-081]
- A Phase II Trial of Cetuximab plus Cisplatin and Irinotecan in Patients with Irinotecan- and Cisplatin-Refractory Metastatic Esophageal and Gastric Cancer
Ilson, David, MD
[Protocol 06-095]
- A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer
Shah, Manish, MD
[Protocol 06-103]
- Early Onset and Familial Gastric Cancer Registry
Shah, Manish, MD
[Protocol 05-118]
- Phase II Trial of Sorafenib for Patients with Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer
Ilson, David, MD
[Protocol 09-016]
- A Phase I Study of KU-0059436 Plus Gemcitabine in Patients with Advanced Pancreatic Cancer
O'Reilly, Eileen, MD
[Protocol 09-073]
- A Phase II Study of AGS-1C4D4 plus Gemcitabine in Patients with Metastatic Pancreatic Cancer
O'Reilly, Eileen, MD
[Protocol 09-086]
- A Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin in Patients with Potentially Resectable Previously Untreated Pancreatic Adenocarcinoma
O'Reilly, Eileen, MD
[Protocol 07-113]
- Clinical Outcomes in Hereditary Cancer
Robson, Mark, MD
[Protocol 06-004]
- Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry
Kurtz, Robert, MD
[Protocol 02-102]
|
